Archives

by in
Entry Author Date Location
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy 02/12/14 Boston
Hunting For Brain Plaques, Neurophage Turns to a Virus 01/31/14 Boston
Crowdfunding Is Coming to Biotech, so Get Ready for a Wild Ride 01/28/13 National
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
Tantalizing Hints of Progress Against ALS for Cytokinetics, Others 11/14/12 San Francisco
Xconomist of the Week: Evan Snyder—Stem Cell Reality Check 05/25/12 San Diego
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines 05/18/12 Boston
Xconomist of the Week: Tom Maniatis on Prize4Life and ALS Research 05/17/12 National
Cytokinetics Shows Hint of Effect With Drug for Lou Gehrig’s Disease 04/25/12 San Francisco
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News 08/20/10 Boston
Life Wants Ion Torrent for Fast Gene Sequencing, Biogen-Idec Takes On Lou Gehrig’s Disease, Two Biotechs Move Toward IPOs, & More San Diego Life Science News 08/19/10 San Diego
Biogen Idec Strikes Potential $345M Deal with Knopp to Develop ALS Drug 08/18/10 Boston
Cytokinetics, Defying the Fashion in Biotech, Sticks with Gradual Science-Based Strategy 08/04/10 San Francisco
San Diego Inventor’s Drug Discovery is Nothing to Laugh (or Cry) About 09/04/09 San Diego
Avanir’s Results for Neurological Drug Triggers Outburst in Trading 08/11/09 San Diego
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News 08/06/09 San Diego
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown 05/07/09 Seattle
State Stem Cell Grants Awarded to Four San Diego Biotechs 12/11/08 San Diego
Ceregene Drug Fails in Parkinson’s Trial 12/01/08 San Diego
Targeted Genetics Cash Will Stretch into First Quarter 11/05/08 Seattle
RXi Takes a Untraditional Route to the Public Market, Now Working To Get Pharma to Pay The Bills 07/18/08 Boston
Targeted Genetics Gets Recommended for up to $2.4 Million Government Grant 07/10/08 Seattle
Page 1 of 1